| PBF | peripheral blod flow; placental blood flow; pulmonary blood flow |
|---|---|
| PBL | peripheral blood leukocyte; peripheral blood lymphocyte; problem-based learning |
| PBV | predicted blood volume; pulmonary blood volume |
| PRBC | packed red blood cells; placental residual blood volume |
| RBF | regional blood flow; regional bone mass; renal blood flow |
hypophosphatemic rickets (저인산 혈성 구루병, 저인산염 혈성 구루병
| fasting blood glucose | <endocrinology, investigation> A method for finding out how much glucose (sugar) is in the blood. The test can show if a person has diabetes. A blood sample is taken in a lab or doctor's office. The test is usually done in the morning before the person has eaten. The normal, nondiabetic range for blood glucose is from 70 to 110 mg/dl, depending on the type of blood being tested. If the level is over 140 mg/dl, it usually means the person has diabetes (except for newborns and some pregnant women). (09 Oct 1997) |
|---|---|
| foetal blood | Blood of the foetus. Exchange of nutrients and waste between the foetal and maternal blood occurs via the placenta. The cord blood is blood contained in the umbilical vessels at the time of delivery. (12 Dec 1998) |
| laky blood | Blood that is undergoing or has undergone laking. See: lake, laky. (05 Mar 2000) |
| fragility of the blood | The susceptibility, or lack of resistance, of erythrocytes to haemolysis when exposed to increasingly hypotonic saline solutions. (12 Dec 1998) |
| Full Blood Count | <haematology, investigation> The determination of the proper number of red blood cells, white blood cells and platelets are present in the patients blood. Acronym: FBC (16 Dec 1997) |
| Lewis blood group | <haematology> A pair of blood group activities associated with the A, B, H substances. Lewis Lea is a separate gene, whereas Leb arises from the combined activity of the enzymes specified by Le(a) and H genes. (18 Nov 1997) |
| lewis blood-group system | A group of dominantly and independently inherited antigens associated with the abo blood factors. They are glycolipids present in plasma and secretions that may adhere to the erythrocytes. The phenotype le(b) is the result of the interaction of the le gene le(a) with the genes for the abo blood groups. (12 Dec 1998) |
| Loeffler's blood culture medium | A culture medium consisting of beef blood serum, sheep blood serum, and beef bouillon containing peptone, glucose, and sodium chloride; used for the isolation of Corynebacterium diphtheriae. (05 Mar 2000) |
| lutheran blood-group system | A complex blood group system having pairs of alternate antigens and amorphic genes, but also subject to a dominant independently segregating repressor. (12 Dec 1998) |
| accelerator factor | <chemical> Heat- and storage-labile plasma glycoprotein which accelerates the conversion of prothrombin to thrombin in blood coagulation. Factor v accomplishes this by forming a complex with factor xa, phospholipid, and calcium (prothrombinase complex). Deficiency of factor v leads to owren's disease. Chemical name: Blood-coagulation factor V (12 Dec 1998) |
| acetate replacement factor | <biochemistry> 1,2 dithiolane 3 valeric acid. Regarded as a coenzyme in the oxoglutarate dehydrogenase complex of the citric acid cycle. Involved generally in oxidative decarboxylations of _ keto acids. A growth factor for some organisms. (18 Nov 1997) |
| adrenal weight factor | A postulated substance of adenohypophysial origin responsible for maintenance of the weight of the adrenal cortex. (05 Mar 2000) |
| adrenocorticotropic releasing factor | Hormone produced by hypothalamus that causes pituitary to secrete adrenocorticotropic hormone. (05 Mar 2000) |
| a-factor | <molecular biology> A protein which is found in the bacterial genus Streptomyces that helps start the production of streptomycin and the process of morphological differentiation. It is used in biotechnology to induce these functions in mutant strains of Streptomyces that cannot produce it themselves. (09 Feb 1998) |
| angiogenesis factor | Substance causing proliferation of new blood vessels. It is found in tissues with high metabolic requirements, such as the retina, and in certain cancers. The factor is also released by hypoxic macrophages at the edges or outer surfaces of wounds and initiates revascularization in wound healing. (12 Dec 1998) |